Carolyn Magill is the CEO of Aetion, the digital health leader with an analytics platform and services transforming real-world data into evidence on which clinical interventions work best, for whom and how much we should pay for them. Customers include global regulatory, life sciences and payer entities. Before Aetion, Carolyn held leadership roles in three companies central to the shift from volume to value in health care. At UnitedHealth, she led Medicare Special Needs Plans nationally, and was COO of the NJ Medicaid health plan. As EVP at Evolent health, Carolyn led efforts to establish value-based contracts on behalf of health systems and provider-led health plans. As CEO of Remedy Partners (now part of CVS), she led the premier provider of software and services for Medicare bundled payment programs. Carolyn has an MBA in health care management from Wharton and a BA from Harvard. She serves on the boards of the National Academy for State Health Policy (NASHP) and Parity.org, advancing gender and racial equity in business leadership. She has been recognized by EY, Goldman Sachs and Crain’s New York for her leadership in health care.